Fusion event
HBV-chr21 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCAC| |CAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGGAC
End
31650591/30278273 (Hg38)
Nearest miRNA
hsa-let-7c/Upstream/3324230; hsa-mir-3197/Downstream/97021;
Upstream sequence
gagtcttggggagggatagcattaggagaaatacctaatgtaggtgacgggttgatgggtgcagcaaaccaccatggcacgtgtatggttatgtaacaaa
Downstream sequence
cctgcacgttctgcacatgcaccccagaacttaaagtatattaaaaaagaaaaaCAGAATATCCAATCCTCATTTCCAAGACTTCTCCAAAGCTAACAAT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.